tm logo
DMBIO Y
Live/Registered
REGISTERED

on 16 Nov 2021

Last Applicant/ Owned by

Yeonsu-gu Incheon, Korea (Songdo-dong)

KR

Serial Number

79302421 filed on 16th Dec 2020

Registration Number

6557534 registered on 16th Nov 2021

in the Principal Register

Correspondent Address

Erica R. Halstead

Abelman, Frayne & Schwab

666 3rd Ave., 10th Fl.

New York NY 10017

Filing Basis

No Filing Basis

Disclaimer

NO DATA

DMBIO Y

The mark consists of the stylized wording "DMBiO Y" with the letter "D" in blue, "M" in red, and "BiO" in grey. The letter "Y" appears as a superscript with the left branch in blue, right branch in red, and the stem in grey. Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in the treatment of gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, for the treatment of dermatitis, skin pigmentation diseases, and in acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, and in allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer

Class [042]
Computer & Software Services & Scientific Services


Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceuticals

Mark Details


Serial Number

No 79302421

Mark Type

No Service Mark

Attorney Docket Number

No 403191

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of the stylized wording "DMBiO Y" with the letter "D" in blue, "M" in red, and "BiO" in grey. The letter "Y" appears as a superscript with the left branch in blue, right branch in red, and the stem in grey.

Legal History


Show more

Status DateAction Taken
16th Feb 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16th Nov 2021REGISTERED-PRINCIPAL REGISTER
31st Aug 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31st Aug 2021PUBLISHED FOR OPPOSITION
29th Aug 2021NOTIFICATION PROCESSED BY IB
11th Aug 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11th Aug 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11th Aug 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28th Jul 2021APPROVED FOR PUB - PRINCIPAL REGISTER
11th Jul 2021REFUSAL PROCESSED BY IB